Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
about
Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic DisordersEndothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisCardiovascular control during exercise in type 2 diabetes mellitusRenal endothelial dysfunction in diabetic nephropathyDiabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?Pathogenesis of diabetic cerebral vascular disease complicationVenous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics.Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitusThe dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsEndothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemRisk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan.High-intensity endurance training results in faster vessel-specific rate of vasorelaxation in type 1 diabetic ratsImmunolocalization of CD34 Positive Progenitor Cells in Diabetic and Non Diabetic Periodontitis Patients - A Comparative Study.Automated quantification reveals hyperglycemia inhibits endothelial angiogenic functionBeneficial effect of troxerutin on diabetes-induced vascular damages in rat aorta: histopathological alterations and antioxidation mechanismHyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients.Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease.Nonsurgical periodontal therapy with/without diode laser modulates metabolic control of type 2 diabetics with periodontitis: a randomized clinical trial.Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation.Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.Assessing the evidence: Exploring the effects of exercise on diabetic microcirculation.Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic miceThe effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathwayExercise-induced endothelial progenitor cell mobilization is attenuated in impaired glucose tolerance and type 2 diabetesImpact of weight loss on oxidative stress and inflammatory cytokines in obese type 2 diabetic patients.Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cellsEnhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice.Emerging roles of hematopoietic cells in the pathobiology of diabetic complications.Pre-eclampsia: the Potential of GSNO Reductase Inhibitors.Role of microRNAs in diabetes and its cardiovascular complications.Treating diabetes today with gliclazide MR: a matter of numbers.Endothelial progenitor cells in diabetes mellitus.Vascular protection with dipeptidyl peptidase-IV inhibitors in diabetes: experimental and clinical therapeutics.Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study.
P2860
Q26740443-FDA6E3B5-A885-40D0-A068-ADC62BB9969DQ26745523-D91E284D-6775-4458-B9D6-7897E18AFFE9Q26780531-06E83E5B-E435-4FC2-912E-B64B12190A0DQ26828811-10EB7A73-6D9B-41EE-A107-701976F8795CQ27021318-27A6B38D-F46E-4DF1-AAC3-E06D49317833Q28082426-15A9D519-B841-452B-9887-1BDC43F24308Q28087462-EABF0328-2CB9-4AB9-900B-CA77C4801E12Q30244606-F9F297E5-377B-4045-8D1E-E88D80D7DDA0Q30396728-1467847D-7DA5-4571-81CD-859FD8A3278AQ33405692-6F5225D2-980F-4FCE-82D6-BECD98CE6470Q33662677-CE68FF41-43F1-4108-91E4-BBE2D095C865Q33776230-2743D391-6437-4751-AC61-0F252CFD1596Q33975637-52718DDE-25D0-4D79-8B20-C6854EFE131FQ34062829-83C8AB83-5D52-45E7-B6A0-752C58AFD5A6Q34257625-967DB64B-E2B9-4978-A064-A1092B607A3BQ34635427-DC0E28E8-995D-480B-84CF-D08F3CB63853Q34910411-C4EC15BD-3F4A-4FB9-9274-DC806A144B04Q35144240-8722D440-2C30-4001-80F3-8B1937C663D0Q35278126-CE793D5C-391F-47E0-8C0A-6E0C2469FC63Q35494661-3189720B-7D64-45AE-8A5F-D70E9A02284AQ35548908-6E057317-1A93-44DB-B221-045C33FF7521Q35821434-BC5364DE-F717-4490-A45F-E7E0F5C60FE7Q35891085-94DEC8FE-621C-46CB-B1E7-F69F7E8670CBQ36124220-D1942358-D683-4747-B717-D4C229BEB72DQ36130309-FDB3E469-1A68-4DA3-B9E5-875609AD325DQ36142104-82DEFEF0-04FB-45B9-8CE1-6F5C94EC4AA1Q36170520-67F7AFBD-6ECF-4692-AAC6-CE2DF0564E0DQ36921163-3C9F1345-A045-4D18-B5B2-0B48CDC253A4Q36975014-709A389E-E992-485F-8B90-43BFDF3C9A59Q37139734-5F85ADE6-9CF5-48EC-8B82-5CE6A6D6545DQ37418336-8F7DC239-7491-4BE3-8DB2-9F196EBB4344Q37621456-A866E374-DB01-4FA4-B485-36030EF9FAC7Q37656092-4D8C2CF8-449F-4806-8D79-701D477C6AA2Q37684896-4E7459A3-DDA0-4583-92A2-008B97172433Q37685502-062A8F33-BB12-43C9-BD2A-AB2A1C3F15D9Q37953896-9148A51D-947A-4192-8892-D0F8B5C4F169Q37961238-405BBED1-58E5-4806-B9A3-E28F82465A24Q38001402-D6AB0832-3EC1-4309-86B9-6893E84ADC11Q38371242-49F075AA-0F24-463D-B2B5-58E7FE9EE57AQ38400520-ECA46896-81ED-43D6-A106-6FB9F1DFD516
P2860
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@en
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@nl
type
label
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@en
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@nl
prefLabel
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@en
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@nl
P2093
P2860
P356
P1433
P1476
Endothelial dysfunction in diabetes: the role of reparatory mechanisms.
@en
P2093
Angelo Avogaro
Gian Paolo Fadini
Lisa Menegazzo
Mattia Albiero
Saula de Kreutzenberg
P2860
P304
P356
10.2337/DC11-S239
P407
P478
34 Suppl 2
P5008
P577
2011-05-01T00:00:00Z